EUVIMEDEUVIMED entdecken
Multizentrische Studie

Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey

Elisavet Chorafa, Elias Iosifidis, Aisha Abdalla Alkhaaldi, Ana Arias, Benhur Sirvan Cetin, Maia De Luca, Marieke Emonts iD, Laura Ferreras-Antolin iD, Elisabetta Ghimenton-Walters, Carlos D Grasa iD, Andreas H Groll, Laura Herrera-Castillo und 16 weitere

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf081 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Elisavet Chorafa und 27 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, 54642, Greece. Hauptthemen laut MEDLINE: Antifungal Agents, Intensive Care Units, Pediatric, Invasive Fungal Infections, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Spanish Ministry of Science and Innovation-Instituto de Salud Carlos III and Fondos FEDER, Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) are highly vulnerable to infections, including invasive fungal diseases and antifungal agents are frequently prescribed. Little is known about antifungal usage in PICUs across Europe.

Methods

A multinational 3-month weekly point-prevalence study for measuring antifungal drug use was organized. Eigtheen PICUs (16 hospitals) in 10 countries in the European region participated. All patients hospitalized in the participating PICUs and receiving systemic antifungals were included. Information about ward demographics was collected once; weekly ward and patient data were collected prospectively for the 12-week study period and entered in REDCap database.

Results

Among 18 PICUs, 8 (44%) followed prophylactic practices for targeted group of patients, 7/18 (39%) had an antifungal stewardship program and the majority (16/18, 89%) had the capacity of biomarker utilization (16/16 galactomannan, 13/16 beta-D-glucan, and 9/16 pan-fungal PCR). One hundred one courses in equal number of patients were recorded; 14 for patients aged <3 month, 87 for patients ≥3 month. Malignancy was the most common underlying condition among patients aged ≥3 month (29%) followed by surgery/trauma (25%), whereas all patients <3 month had undergone a recent surgery. Indication for antifungal prescribing was prophylaxis in 38% and treatment in 62% [empirical (57%), preemptive (13%), and targeted (30%)]. Fluconazole was the most common agent both for prophylaxis and treatment, whereas liposomal amphotericin B was the most frequent agent for targeted treatment. The majority (63%) of patients on prophylaxis were oncology or transplant patients. Common reasons for empirical and targeted treatment were persistent fever/other signs of infections in high-risk patients (61%) and Candida infections (100%), respectively. For targeted treatment, the most frequent pathogens were Candida albicans (37%) and Candida parapsilosis (32%).

Conclusions

Most antifungal prescriptions across European PICUs were for treatment. Fluconazole was the most frequently prescribed antifungal. These surveillance data can guide antifungal stewardship strategies in PICUs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsIntensive Care Units, PediatricInvasive Fungal InfectionsDrug PrescriptionsPractice Patterns, Physicians'HumansEuropeChild, PreschoolInfantChildFemaleMaleAdolescentProspective StudiesInfant, NewbornPrevalenceAntimicrobial Stewardship

Stichwörter der Autor:innen

antifungal prescriptionsantifungal stewardshipfluconazoleliposomal amphotericin Bpediatric intensive care unit

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Infectious Diseases Unit, 3rd Department of Pediatrics, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, 54642, Greece.
  • Al Qassimi Women's and Children's Hospital, Sharjah, 61405, United Arab Emirates.
  • Hospital 12 de Octubre, Madrid, 28041, Spain.
  • Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University, Kayseri, 38039, Türkiye.
  • Infectious Disease Unit, IRCCS, Bambino Gesù Children's Hospital, Rome, 00165, Italy.
  • Paediatric Immunology, Department of Infectious Diseases and Allergy, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE2 4AA, United Kingdom.

ORCID-Profile: Marieke Emonts, Laura Ferreras-Antolin, Carlos D Grasa, Elena Rincón-López, Adilia Warris, Emmanuel Roilides

Förderung

  • Spanish Ministry of Science and Innovation-Instituto de Salud Carlos III and Fondos FEDER
  • Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER

Zitieren

APA

Chorafa, E., Iosifidis, E., Alkhaaldi, A. A., Arias, A., Cetin, B. S., De Luca, M., Emonts, M., Ferreras-Antolin, L., Ghimenton-Walters, E., Grasa, C. D., Groll, A. H., Herrera-Castillo, L., Lehrnbecher, T., Manzanares, A., Masjosthusmann, K., Melendo, S., Mendoza-Palomar, N., Paulus, S., Rincón-López, E., …, & Roilides, E. (2025). Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf081

Vancouver

Chorafa E, Iosifidis E, Alkhaaldi AA, Arias A, Cetin BS, De Luca M, et al. Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf081

BibTeX
@article{Chorafa2025,
  author = {Chorafa, Elisavet and Iosifidis, Elias and Alkhaaldi, Aisha Abdalla and Arias, Ana and Cetin, Benhur Sirvan and De Luca, Maia and Emonts, Marieke and Ferreras-Antolin, Laura and Ghimenton-Walters, Elisabetta and Grasa, Carlos D and Groll, Andreas H and Herrera-Castillo, Laura and Lehrnbecher, Thomas and Manzanares, Angela and Masjosthusmann, Katja and Melendo, Susana and Mendoza-Palomar, Natalia and Paulus, Stéphane and Rincón-López, Elena and Romani, Lorenza and Sdougka, Maria and Solopova, Galina and Strenger, Volker and Tedford, Kara and Tzika, Christina and Warris, Adilia and Zsigmond, Borbala and Roilides, Emmanuel},
  title = {Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf081}
}
Kostenlos starten →